Tag Archives: Cell and gene therapies

Janssen acquires the rights to a new gene therapy for AMD

[ad_1] HMR59 targets geographic atrophy: a severe form of advanced AMD. In geographic atrophy, complement overactivity destroys cells in the macula, the central part of the retina responsible for central vision and fine detail vision, progressing to blindness. Patients with AMD often have low levels of the CD59 protein, which …

Read More »